Part (i) Last 12 months prevalence all adults: last survey available for each Member State (from 2000 onwards)

Country

Geographical area

Year

Reference

Age range all adults

Sample size all adults

Cannabis (%)

Cocaine (%) (1)

Amphetamines (%) (2)

Ecstasy (%) (3)

LSD (%)

Belgium

National

2004

(6)

15–64

:

5.0

:

:

:

:

Bulgaria

National

2008

(3)

15–64

5139

2.7

0.7

0.9

0.7

0.0

Czech Republic

National

2008

(3)

15–64

4500

15.2

0.7

1.7

3.7

2.1

Denmark

National

2008

(5)

16–64

3408

5.5

1.4

1.2

0.4

0.1

Germany

National

2006

(7)

18–64

7912

4.7

0.6

0.5

0.4

0.1

Estonia

National

2008

(3)

15–64

1401

6.0

0.7

1.1

1.2

0.3

Ireland

National

2006–07

(5)

15–64

4967

6.3

1.7

0.4

1.2

0.2

Greece

National (except Aegean and Ionian Islands)

2004

(3)

15–64

4351

1.7

0.1

0.0

0.2

0.1

Spain

National

2007-08

(7)

15–64

23715

10.1

3.1

0.9

1.2

:

France

National

2005

(6)

15–64

25879

8.6

0.6

0.1

0.4

0.1

Italy

National

2008

(4)

15–64

10940

14.3

2.1

0.4

0.7

:

Cyprus

National

2006

(1)

15–64

3504

2.1

0.6

0.3

1.0

0.5

Latvia

National

2007

(2)

15–64

4500

4.9

0.5

0.9

1.5

0.2

Lithuania

National

2008

(2)

15–64

4777

5.6

0.2

0.7

1.0

0.2

Luxembourg

:

:

:

:

:

:

:

:

:

:

Hungary

National

2007

(3)

18–64

2710

2.3

0.2

0.5

0.5

0.2

Malta

National

2001

(1)

18–64

1755

0.8

0.3

0.0

0.2

0.1

Netherlands

National

2005

(3)

15–64

4516

5.4

0.6

0.3

1.2

0.1

Austria

National

2008

(2)

15–64

3761

3.5

0.9

0.5

0.5

0.2

Poland

National

2006

(2)

15–64

2859

2.7

0.2

0.7

0.3

0.1

Portugal

National

2007

(2)

15–64

12202

3.6

0.6

0.2

0.4

0.1

Romania

National

2007

(2)

15–64

6797

0.4

0.0

0.0

0.1

0.0

Slovenia

National

2007

(1)

15–64

1724

3.1

:

:

:

:

Slovakia

National

2006

(6)

15–64

1305

6.9

0.6

0.3

1.6

:

Finland

National

2006

(7)

15–64

2802

3.6

0.5

0.6

0.5

0.1

Sweden

National

2008

(5)

15–64

22095

1.2

0.5

0.8

0.1

:

Sweden

National

2008

(10)

16-64

8343

1.9

:

:

:

:

United Kingdom

England and Wales

2008-09

(12)

16-59

28407

7.9

3.0

1.2

1.8

0.2

United Kingdom

Northern Ireland

2007-08

(16)

16–64

2731

4.8

1.6

0.8

1.4

0.1

United Kingdom

Scotland

2006

(19)

16–59

3157

11.0

3.8

2.2

3.2

0.6

United Kingdom

United Kingdom

2006

(21)

16–59

:

8.4

2.7

1.4

1.9

0.2

Croatia

:

:

:

:

:

:

:

:

:

:

Turkey

:

:

:

:

:

:

:

:

:

:

Norway

National

2004

(2)

15–64

2669

4.6

0.8

1.1

0.5

0.2

Notes:

(1) Cocaine, any form.

(2) For Belgium National 2001 and for Metropolitan France 1995: amphetamine and ecstasy.

(3) For Spain: ecstasy and other synthetic drugs.

This table aims to provide an overview of national surveys. Exceptionally, some relevant regional surveys are presented. Some city surveys reported by countries were not included as they tend to produce higher prevalence estimates, which are not comparable with estimates for whole countries (or large regions with both urban and rural areas). Athens was included as a reference point for the 1993 survey.

In surveys with small sample sizes results should be interpreted with caution.

Countries were asked to report results using, as far as possible, EMCDDA standard age groups (all adults: 15–64, young adults: 15–34). In countries where age ranges are more restrictive, prevalence estimates may tend to be slightly higher. Some countries have recalculated their prevalence figures using the EMCDDA standard age groups.

Sources:

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>